Search research articles
Contact Us
Filters
Showing results (31-40 of 51) with videos related to
Page
of 6
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 20, 2005
Safety and efficacy of gatifloxacin therapy for children with recurrent acute otitis media (AOM) and/or AOM treatment failure
Michael E Pichichero, Adriano Arguedas, Ron Dagan, et al.
The Pediatric Infectious Disease Journal
|
January 11, 2011
Acute otitis media severity of symptom score in a tympanocentesis study
Nader Shaikh, Elaine E L Wang, Adriano Arguedas, et al.
Journal of Clinical Pharmacology
|
November 23, 2016
Cefiderocol, a Siderophore Cephalosporin for Gram-Negative Bacterial Infections: Pharmacokinetics and Safety in Subjects With Renal Impairment
Takayuki Katsube, Roger Echols, Juan Camilo Arjona Ferreira, et al.
The Journal of Antimicrobial Chemotherapy
|
February 13, 2023
In vivo efficacy & resistance prevention of cefiderocol in combination with ceftazidime/avibactam, ampicillin/sulbactam or meropenem using human-simulated regimens versus Acinetobacter baumannii
Christian M Gill, Debora Santini, Miki Takemura, et al.
The Pediatric Infectious Disease Journal
|
April 9, 2005
Randomized, investigator-blinded, multicenter study of gatifloxacin versus amoxicillin/clavulanate treatment of recurrent and nonresponsive otitis media in children
Xavier Sáez-Llorens, Adib Rodriguez, Adriano Arguedas, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 11, 2022
Cefiderocol for the Treatment of Infections Due to Metallo-B-lactamase-Producing Pathogens in the CREDIBLE-CR and APEKS-NP Phase 3 Randomized Studies
Jean Francois Timsit, Mical Paul, Ryan K Shields, et al.
International Journal of Antimicrobial Agents
|
June 10, 2023
Prospective role of cefiderocol in the management of carbapenem-resistant Acinetobacter baumannii infections: Review of the evidence
Marin Kollef, Herve Dupont, David E Greenberg, et al.
Antimicrobial Agents and Chemotherapy
|
June 21, 2017
Efficacy of Cefiderocol against Carbapenem-Resistant Gram-Negative Bacilli in Immunocompetent-Rat Respiratory Tract Infection Models Recreating Human Plasma Pharmacokinetics
Shuhei Matsumoto, Christine M Singley, Jennifer Hoover, et al.
International Journal of Antimicrobial Agents
|
November 6, 2018
In vitro activity of cefiderocol, a siderophore cephalosporin, against a recent collection of clinically relevant carbapenem-non-susceptible Gram-negative bacilli, including serine carbapenemase- and metallo-β-lactamase-producing isolates (SIDERO-WT-2014 Study)
Krystyna M Kazmierczak, Masakatsu Tsuji, Mark G Wise, et al.
The Pediatric Infectious Disease Journal
|
April 9, 2005
Randomized, investigator-blinded, multicenter, comparative study of gatifloxacin versus amoxicillin/clavulanate in recurrent otitis media and acute otitis media treatment failure in children
Lawrence Sher, Adriano Arguedas, Michael Husseman, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 51) with videos related to
Sort By:
Page
of 6
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 20, 2005
Safety and efficacy of gatifloxacin therapy for children with recurrent acute otitis media (AOM) and/or AOM treatment failure
Michael E Pichichero, Adriano Arguedas, Ron Dagan, et al.
The Pediatric Infectious Disease Journal
|
January 11, 2011
Acute otitis media severity of symptom score in a tympanocentesis study
Nader Shaikh, Elaine E L Wang, Adriano Arguedas, et al.
Journal of Clinical Pharmacology
|
November 23, 2016
Cefiderocol, a Siderophore Cephalosporin for Gram-Negative Bacterial Infections: Pharmacokinetics and Safety in Subjects With Renal Impairment
Takayuki Katsube, Roger Echols, Juan Camilo Arjona Ferreira, et al.
The Journal of Antimicrobial Chemotherapy
|
February 13, 2023
In vivo efficacy & resistance prevention of cefiderocol in combination with ceftazidime/avibactam, ampicillin/sulbactam or meropenem using human-simulated regimens versus Acinetobacter baumannii
Christian M Gill, Debora Santini, Miki Takemura, et al.
The Pediatric Infectious Disease Journal
|
April 9, 2005
Randomized, investigator-blinded, multicenter study of gatifloxacin versus amoxicillin/clavulanate treatment of recurrent and nonresponsive otitis media in children
Xavier Sáez-Llorens, Adib Rodriguez, Adriano Arguedas, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 11, 2022
Cefiderocol for the Treatment of Infections Due to Metallo-B-lactamase-Producing Pathogens in the CREDIBLE-CR and APEKS-NP Phase 3 Randomized Studies
Jean Francois Timsit, Mical Paul, Ryan K Shields, et al.
International Journal of Antimicrobial Agents
|
June 10, 2023
Prospective role of cefiderocol in the management of carbapenem-resistant Acinetobacter baumannii infections: Review of the evidence
Marin Kollef, Herve Dupont, David E Greenberg, et al.
Antimicrobial Agents and Chemotherapy
|
June 21, 2017
Efficacy of Cefiderocol against Carbapenem-Resistant Gram-Negative Bacilli in Immunocompetent-Rat Respiratory Tract Infection Models Recreating Human Plasma Pharmacokinetics
Shuhei Matsumoto, Christine M Singley, Jennifer Hoover, et al.
International Journal of Antimicrobial Agents
|
November 6, 2018
In vitro activity of cefiderocol, a siderophore cephalosporin, against a recent collection of clinically relevant carbapenem-non-susceptible Gram-negative bacilli, including serine carbapenemase- and metallo-β-lactamase-producing isolates (SIDERO-WT-2014 Study)
Krystyna M Kazmierczak, Masakatsu Tsuji, Mark G Wise, et al.
The Pediatric Infectious Disease Journal
|
April 9, 2005
Randomized, investigator-blinded, multicenter, comparative study of gatifloxacin versus amoxicillin/clavulanate in recurrent otitis media and acute otitis media treatment failure in children
Lawrence Sher, Adriano Arguedas, Michael Husseman, et al.
Page
of 6